新华社:美国阿片类止痛药滥用与成瘾危机严重,针灸迎来发展时机

2017-11-22 郭一娜 林小春等 中国中医

新华社华盛顿11月20日电 莎伦又一次躺在熟悉的床位上,针灸师樊蓥轻、稳、准地在她肩部和颈部的重要穴位扎上了细细的针。莎伦的耳边响起了柔和温馨的轻音乐,她慢慢闭上眼,呼吸均匀,心情平和,享受着45分钟的美好时光。

新华社华盛顿11月20日电 莎伦又一次躺在熟悉的床位上,针灸师樊蓥轻、稳、准地在她肩部和颈部的重要穴位扎上了细细的针。莎伦的耳边响起了柔和温馨的轻音乐,她慢慢闭上眼,呼吸均匀,心情平和,享受着45分钟的美好时光。

樊蓥是美国弗吉尼亚州与华盛顿特区持照针灸师,他的诊所——美京中医院位于弗吉尼亚州梅克林小镇。300平方米左右的诊所内共有15个床位。身为一名职业律师的莎伦·希普勒已经忘了这是她第几十次来到诊所接受治疗。

喜欢运动的莎伦今年60岁,她与针灸的缘分始于3年前。当时她得了肌腱炎,西医告诉她最快也要几个月才能恢复。有朋友向她推荐了樊蓥,后者仔细查看了腿伤后告诉她:“两周来做一次治疗,3次后就能康复。”

西医的数个月康复和针灸的3次就好,这差距大得让莎伦有些不敢相信。面对莎伦的怀疑,樊蓥只是笑笑说,咱们试试看吧。

出乎莎伦意料,一个疗程下来,肌腱炎竟奇迹般康复,她矫健而轻盈的身姿很快又重现跑道。

“太神奇了!”她在接受新华记者采访时禁不住多次感叹。此后,莎伦对中医从信赖到依赖,身体稍有不适,首先想到的就是看中医。


律师工作压力大,导致莎伦睡眠不好。多次针灸后,她感觉睡眠明显改善。每次莎伦感觉有感冒前兆,或者美国将有流感,她就赶紧来找樊蓥。莎伦相信,针灸疗法帮她提高了免疫力。最近她肩部受伤,又是针灸让她免受了手术折磨。

如今,莎伦不仅是针灸的粉丝,更成了针灸的传播者。亲朋好友生病了,她会向大家推荐中医。85岁的老母亲经常背疼,她正力劝母亲尝试针灸疗法。

莎伦对中西医治疗差别感触很深。“樊蓥和他的助手对我十分耐心、细致,我感到很放松,恢复得也快。如果是去看西医,幸运的话,医生会给我10分钟,然后就开药,或安排更多检查。看到我肩痛或脚痛,西医会给我打止痛针。我可不喜欢打针和手术。所以,我会来针灸诊所。我虽不知道针灸原理,但我知道它有效。”

“美国的医疗体系有很大问题,不少人在寻找替代疗法。”莎伦说,“我坚信今后会有越来越多人看中医。”


正如莎伦所说,当前,美国阿片类止痛药物滥用与成瘾危机日益严重,在这方面针灸大有可为。

阿片类止痛药包括杜冷丁、吗啡等,镇痛作用强大,但有极强成瘾性。官方数据显示,每天平均有91名美国人死于过量服用阿片类药物,年均超过3万人。10月底,美国总统特朗普向阿片滥用现象宣战,称“阿片类药物滥用是美国历史乃至全世界范围内最严重的药物危机”。

严峻现实迫使西医接受非药物疗法。而在各种非药物疗法中,针灸以有效和廉价脱颖而出。中国数十年来持续进行的中医机理研究形成大量成果,此时成为有力佐证。美国国家科学、工程和医学学院7月发布题为《疼痛管理与阿片类药物流行》的报告指出,近几十年来针灸止痛已成为普遍做法,包括针灸在内的一些非药物干预手段是止痛的有力工具。

不少旅美针灸师预感,针灸在美国可能迎来了发展的好时机。目前,经过业内人士长达40多年的努力,美国50个州中有46个州以及华盛顿特区已立法让针灸行医合法化。而在这个过程中,樊蓥的诊所,从15年前的无人问津到如今每周稳定在150位左右病人。个中改变,反映了针灸在美国从举步维艰到逐步受到认可的历程。

正是看到针灸治疗的良好效果和较大的市场空间,美国一些理疗师也开始学习针灸,但这也带来了一些干扰。美国的针灸与东方医学硕士需要学习2000小时以上,而美国部分理疗师将针灸改成“干针”,只需学习50个学时就可行医,且未接受中医针灸的完整训练,更缺乏中医针灸处理多科疾病的全能知识和技能储备。所谓干针是指理疗师用针头对激痛点进行针刺的方法。

“美国国内一些理疗师的做法是在混淆视听,给针灸在美发展带来挑战。”谈起这些“干扰”,樊蓥皱起眉头。

目前,莎伦所参加的医疗保险覆盖针灸治疗,可报销80%。10月,美国参众两院议员同意在老年人与残疾人联邦医保的一个补充项目中包括针灸。如果该法案最终通过,相信将进一步推动针灸在美国的发展。

11月,多个美国中医针灸团体在学术期刊上正式发布《针灸应对阿片类药物危机白皮书2017》,樊蓥也是作者之一。这份白皮书被送交美国卫生与公众服务部,并得到积极回复。

也是在初冬,作为全美中医药学会(ATCMA)副会长的樊蓥参加了首次在美国国会举办的针灸推介会,向议员推荐和介绍针灸在止痛与治疗阿片类药物滥用与成瘾方面的作用。现场气氛热烈,40多人还尝试了耳针。“在国会和联邦政府层面,我们还将继续推动,为针灸在美迎来真正春天不懈努力。”樊蓥说。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2018-01-05 zchen
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-29 天涯183

    非常好的文章.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-24 lhlxtx
  6. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-23 thlabcde

    好资料学习了!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1654696, encodeId=e020165469658, content=<a href='/topic/show?id=ebe99e884c4' target=_blank style='color:#2F92EE;'>#阿片类止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97884, encryptionId=ebe99e884c4, topicName=阿片类止痛药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=297424527812, createdName=naiwu85, createdTime=Wed Sep 05 02:43:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701555, encodeId=241b1e015558b, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Fri Jan 05 11:43:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265392, encodeId=23282653920c, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Wed Nov 29 19:52:44 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289980, encodeId=99911289980f4, content=<a href='/topic/show?id=50e36316e7d' target=_blank style='color:#2F92EE;'>#止痛药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63167, encryptionId=50e36316e7d, topicName=止痛药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309071, encodeId=72d813090e1d9, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405544, encodeId=4a35140554469, content=<a href='/topic/show?id=597b631634d' target=_blank style='color:#2F92EE;'>#止痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63163, encryptionId=597b631634d, topicName=止痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8da42553722, createdName=zhangxingru, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542129, encodeId=c180154212977, content=<a href='/topic/show?id=61ae5812230' target=_blank style='color:#2F92EE;'>#新华社#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58122, encryptionId=61ae5812230, topicName=新华社)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5a613357359, createdName=124984edm26暂无昵称, createdTime=Fri Nov 24 09:43:00 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263730, encodeId=899c263e3049, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Thu Nov 23 22:06:12 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263417, encodeId=040e26341e7f, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Nov 22 21:17:11 CST 2017, time=2017-11-22, status=1, ipAttribution=)]
    2017-11-22 戒馋,懒,贪

    谢谢分享学习了

    0

相关资讯

调查:因治疗成本高,美国27%癌症患者放弃部分治疗

据美国侨报网报道,美国临床肿瘤学会(ASCO)一项最新调查显示,美国癌症治疗的高成本已导致超过四分之一的患者无奈放弃了部分治疗。报告称,27%的癌症患者或癌症患者直系亲属承认,为了降低医疗费用他们不得已放弃了部分治疗或采取了其他弥补治疗措施。这项针对4000多位美国成年人的调查显示,为了省钱,近10%的人承认他们放弃了预约医生,而8%的人选择了拒绝接受治疗、推迟填写或不填写处方,或未遵循医生规定的

美国新版高血压指南:主要看点有哪些?

2017年美国心脏协会(AHA)年会将于2017年11月11日-15日召开。预期11月13日将由ACC与AHA共同颁布美国新版高血压指南。随着JNC系列高血压指南寿终正寝,ACC/AHA高血压指南或将取代JNC指南的地位而成为高血压防治策略的风向标。新指南主要有以下几个方面值得重点关注

美国癌症患者何弃疗?

一项新的调查揭示了导致27%的美国癌症患者无奈放弃部分治疗的原因。

2018美国全新患者安全目标发布

2017年11月15日,美国医院评审联合委员会(The Joint Commission,TJC)发布了《2018年患者安全目标》(2018 NPSG),2018年1月1日将在以下8种不同类型的卫生保健机构实施。2018 National Patient Safety Goals编译自:The Joint Commission.门诊(Ambulatory Health Care)行为健康机构(Be

为什么在美国开诊所很容易,而在中国很难?

前不久,美国伊利诺大学医学院神经内科医生王明涛一篇关于“美国开诊所有多爽”(点击查看文章)的文章,经医学界转载后,很快引起热议。王医生在文章中表示,“美国医生开业,相比国内简直是天壤之别”。这里的“天壤之别”,集中体现在“政府与医生的关系”上面。在美国开诊所,消防、卫生、环保统统不用去,不用到处“烧香”,医生只需要心无旁骛地专心看病即可。比如在美国,申请一个州的执照,只需要打电话向州执照管理单位寄

医生到底累不累?美国1/4医生不想干了

除了门诊和手术之外,很多医生在工作之余还要花大量时间写病历和论文,长期劳累已成为我国医生生活的常态,那么美国医生的工作现状是怎样的呢?他们累不累呢?一项新的调查显示,约有1/5美国医生计划在明年减少临床工作时间,1/4医生想在两年内离开目前的工作岗位。与其他美国人相比,医生更容易出现职业倦怠的现象。为了评估美国医生的职业规划及满意度,美国医学协会的研究人员在2014年开展了一项全美范围的调查研究,